Physician profile
Grace Higgins
NPI 1174013890
$506.72
in general payments reported to CMS, 2019-2025
12 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.79 · 2022: $30.41 · 2023: $34.17 · 2024: $89.67 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $161.56 | 2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $64.58 | 2021-2024 | Fasenra |
| Pfizer INC. | $54.04 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $44.90 | 2025 | Camzyos, Eliquis |
| United Therapeutics Corporation | $34.17 | 2023 | Tyvaso |
| Glaxosmithkline, LLC. | $33.08 | 2025 | Trelegy Ellipta |
| Mylan Specialty L.P. | $25.00 | 2024 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $24.55 | 2025 | |
| Insmed, INC. | $20.01 | 2021 | |
| Mallinckrodt Hospital Products INC. | $16.92 | 2021 | |
| Abbvie INC. | $14.59 | 2025 | |
| Resmed Corp | $13.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.